Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets Journal Article


Authors: Wang, T.; Pine, A. R.; Kotini, A. G.; Yuan, H.; Zamparo, L.; Starczynowski, D. T.; Leslie, C.; Papapetrou, E. P.
Article Title: Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets
Abstract: Human cancers arise through the sequential acquisition of somatic mutations that create successive clonal populations. Human cancer evolution models could help illuminate this process and inform therapeutic intervention at an early disease stage, but their creation has faced significant challenges. Here, we combined induced pluripotent stem cell (iPSC) and CRISPR-Cas9 technologies to develop a model of the clonal evolution of acute myeloid leukemia (AML). Through the stepwise introduction of three driver mutations, we generated iPSC lines that, upon hematopoietic differentiation, capture distinct premalignant stages, including clonal hematopoiesis (CH) and myelodysplastic syndrome (MDS), culminating in a transplantable leukemia, and recapitulate transcriptional and chromatin accessibility signatures of primary human MDS and AML. By mapping dynamic changes in transcriptomes and chromatin landscapes, we characterize transcriptional programs driving specific transitions between disease stages. We identify cell-autonomous dysregulation of inflammatory signaling as an early and persistent event in leukemogenesis and a promising early therapeutic target. © 2021 Elsevier Inc.
Keywords: leukemogenesis; innate immunity; aml; clonal evolution; inflammatory response; hematopoietic stem/progenitor cells; gene editing; irak1 inhibitor; irak4 inhibitor; ube2n inhibitor
Journal Title: Cell Stem Cell
Volume: 28
Issue: 6
ISSN: 1934-5909
Publisher: Cell Press  
Date Published: 2021-06-03
Start Page: 1074
End Page: 1089.e7
Language: English
DOI: 10.1016/j.stem.2021.01.011
PUBMED: 33571445
PROVIDER: scopus
PMCID: PMC8178190
DOI/URL:
Notes: Article -- Export Date: 1 July 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christina Leslie
    191 Leslie
  2. Han   Yuan
    8 Yuan
  3. Allison Pine
    6 Pine